MARK L. WOLF, District Judge.
At the hearings on February 7 and 8, 2017, the court intends to have the parties address first defendants' motion to exclude the testimony of Drs. Wurm and Butler (Docket No, 339) and next plaintiff's motion to limit the testimony of Dr. Glacken (Docket No. 341). As previously discussed, the court, rather than the experts, will instruct the jury on the law, including providing interim instructions during trial to assist the jury in understanding any admissible expert testimony. As the parties recognize, an expert will not be permitted to provide the jury an opinion as to legal standards.
In addition, to admit expert testimony, the court must find, pursuant to Federal Rule of Evidence 104(a), that it is more likely than not that the expert's methods are reliable and that they have been reliably applied to the relevant evidence. This requires, among other things, a persuasive explanation of how reliable methods are linked to each of the expert's opinions.
In addition, the parties shall be prepared to inform the court of the availability of their respective experts for
After hearing argument on the motions in limine concerning the experts, the court intends to address the questions of the proper measure of damages and the propriety of injunctive relief if plaintiffs prevail at trial. With regard to defendants' recent contention that plaintiffs lack standing and, therefore, the court does not have subject-matter jurisdiction, the court discerns an issue the parties have not addressed.
Even if Janssen's failure to join one of the inventors of the '083 patent, Joseph Horwitz, in its 2015 suit was a defect in standing, the Federal Circuit has held that parties can cure such a defect by joining the absent party. The Federal Circuit has permitted parties to do so either with the party's consent under Federal Rule of Civil Procedure 21 or, in certain circumstances, involuntarily under Federal Rule of Civil Procedure 19.
ordinarily, at least, an amendment adding a new plaintiff would relate back to the date of the filing of the original complaint.
After the argument concerning damages, the court will hear further argument on Hospira's motion for summary judgment. The court will then consider the disputes concerning jury instructions, the remaining motions in limine, and matters relating to jury selection and the conduct of the trial.
As it does not appear likely that all of the foregoing matters will be resolved on or before February 8, 2017, the court is considering conducting further hearings the week of February 13, 2017, and beginning trial on February 20, 2017. The parties shall be prepared to discuss this as well.
Although more difficult to parse, the proposed testimony of Dr. Glacken raises many similar issues concerning how, if at all, his methodology is linked to many of his conclusions. The parties should be prepared to discuss these issues as well.